Stockscreener 앱 받기
0.00
100.00%
-8.68
전일 마감가:
$8.68
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$544.94M
수익:
$91.06M
순이익/손실:
$-503.14M
주가수익비율:
0.00
EPS:
-8.39
순현금흐름:
$-424.74M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$9.36
Sage Therapeutics Inc Stock (SAGE) Company Profile
명칭
Sage Therapeutics Inc
전화
617-299-8380
주소
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
SAGE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SAGE
Sage Therapeutics Inc
|
0.00 | 544.94M | 91.06M | -503.14M | -424.74M | -8.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sage Therapeutics Inc Stock (SAGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-11 | 재개 | BofA Securities | Underperform |
| 2024-11-21 | 업그레이드 | RBC Capital Mkts | Underperform → Sector Perform |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-10-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-30 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-29 | 개시 | Citigroup | Sell |
| 2024-05-29 | 개시 | Robert W. Baird | Neutral |
| 2024-04-17 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-12-12 | 개시 | Deutsche Bank | Hold |
| 2023-08-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-08-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-08-08 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-07 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-08-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2023-08-07 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-08-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-03-13 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-11-01 | 개시 | Loop Capital | Hold |
| 2022-03-31 | 개시 | Berenberg | Hold |
| 2021-11-02 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-06-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-07 | 개시 | Piper Sandler | Overweight |
| 2021-02-26 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-02-25 | 재확인 | H.C. Wainwright | Neutral |
| 2021-02-02 | 재개 | Raymond James | Mkt Perform |
| 2021-01-22 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2021-01-04 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-01-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-04 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-12-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-11-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-06 | 재확인 | H.C. Wainwright | Neutral |
| 2020-09-11 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-08-10 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-05-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-04-08 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-18 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-06 | 개시 | Citigroup | Buy |
| 2020-02-28 | 재확인 | H.C. Wainwright | Neutral |
| 2020-02-06 | 개시 | Mizuho | Neutral |
| 2019-12-06 | 재확인 | RBC Capital Mkts | Outperform |
| 2019-12-05 | 재확인 | Guggenheim | Buy |
| 2019-12-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-10-30 | 개시 | H.C. Wainwright | Neutral |
| 2019-05-23 | 개시 | Wedbush | Outperform |
| 2019-04-25 | 개시 | Jefferies | Buy |
| 2018-12-14 | 개시 | Wolfe Research | Outperform |
| 2018-10-11 | 개시 | Oppenheimer | Outperform |
모두보기
Sage Therapeutics Inc 주식(SAGE)의 최신 뉴스
Postpartum Depression Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research, Bristol-Myers - Barchart.com
How Sage Therapeutics Inc. stock compares to industry benchmarksInsider Selling & Free Expert Verified Stock Movement Alerts - Newser
Will Sage Therapeutics Inc. (SG7) stock enhance shareholder valueJuly 2025 Review & Technical Pattern Alert System - Newser
How big funds are accumulating Sage Therapeutics Inc. (SG7) stockStop Loss & Precise Swing Trade Alerts - Newser
Will Sage Therapeutics Inc. (SG7) stock outperform small cap peersDip Buying & Long-Term Safe Investment Ideas - Newser
Why Sage Therapeutics Inc. stock remains a top recommendationJuly 2025 Closing Moves & Safe Entry Zone Tips - Newser
How Sage Therapeutics Inc. (SG7) stock benefits from digital adoptionJuly 2025 Selloffs & Breakout Confirmation Trade Signals - Newser
What is the fair value of Sage Therapeutics Inc. stock now2025 Momentum Check & Consistent Profit Trading Strategies - Newser
Is Sage Therapeutics Inc. stock a buy on dips2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - BỘ NỘI VỤ
What analysts say about Sage Therapeutics Inc stockInsider Trading Compliance & High Return Wealth Building - earlytimes.in
Is Sage Therapeutics Inc. (SG7) stock undervalued after correctionWeekly Gains Summary & Real-Time Volume Spike Alerts - newser.com
What technical patterns form on Sage Therapeutics Inc. (SG7) stock chartsRate Cut & Weekly Market Pulse Updates - newser.com
How Sage Therapeutics Inc. stock benefits from global expansionJuly 2025 Drop Watch & Advanced Technical Signal Analysis - newser.com
Can Sage Therapeutics Inc. (SG7) stock resist broad market declines2025 Trading Recap & AI Forecast for Swing Trade Picks - newser.com
Is Sage Therapeutics Inc. (SG7) stock a buy during volatile marketsTrade Entry Report & Weekly Setup with ROI Potential - newser.com
Can Sage Therapeutics Inc. (SG7) stock sustain revenue momentumWeekly Profit Analysis & Fast Entry Momentum Alerts - newser.com
Sage Therapeutics Inc. stock momentum explainedJuly 2025 WrapUp & Fast Gain Stock Tips - newser.com
Sage Therapeutics Inc. stock prediction for this weekWeekly Trade Summary & Consistent Profit Focused Trading Strategies - newser.com
Will Sage Therapeutics Inc. benefit from macro trends2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Will Sage Therapeutics Inc. (SG7) stock beat value stocks2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
Why Sage Therapeutics Inc. (SG7) stock stays on top picks2025 Volatility Report & Precise Swing Trade Entry Alerts - newser.com
How Sage Therapeutics Inc. stock compares to growth peers2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
Will Sage Therapeutics Inc. stock recover after recent dropWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com
Published on: 2025-11-16 05:15:30 - newser.com
Sage Therapeutics Inc SG7 Stock Analysis and ForecastEarnings Revision Updates & Free Stock Trading Workshops - earlytimes.in
Sage Therapeutics Inc (SAGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):